CRYOPORT, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount
CRYOPORT, INC. (CYRX) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount of $1.40 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-07.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2025-03-07
- CRYOPORT, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2024 was $1.40M, a 15.84% decline from fiscal 2023.
- CRYOPORT, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2023 was $1.66M, a 11.75% decline from fiscal 2022.
- CRYOPORT, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2022 was $1.88M.
- CRYOPORT, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2021 was -$7.54M.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 9 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month as first filed |
|---|---|---|---|
| 2024-12-31 | $1.40M 10-K · filed 2025-03-07 | ||
| 2023-12-31 | $1.66M 10-K · filed 2025-03-07 | ||
| 2022-12-31 | $1.88M 10-K · filed 2025-03-07 | ||
| 2021-12-31 | -$7.54M 10-K · filed 2024-03-13 | ||
| 2020-12-31 | -$2.68M 10-K · filed 2023-02-28 | ||
| 2019-12-31 | $480.00K 10-K · filed 2022-02-28 | $1.47M 10-K · filed 2020-03-10 | |
| 2018-12-31 | $472.00K 10-K · filed 2020-03-10 | ||
| 2017-12-31 | $503.00K 10-K · filed 2019-03-13 | ||
| 2016-12-31 | $607.00K 10-KT · filed 2017-03-13 | $607.00K 10-K · filed 2018-03-08 | |
| 2016-03-31 | $270.00K 10-KT · filed 2017-03-13 | ||
| 2015-03-31 | $0.00 10-K · filed 2016-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |